Searched for
ZYDUS LIFE JEFFERIES
Zydus Lifesciences shares in focus after Ahmedabad oncology unit gets USFDA EIRZydus Lifesciences got a USFDA clearance upgrade for its Ahmedabad oncology plant, moving from OAI to VAI status after a June inspection—a ...- Trump tariff hike hits Dalal Street: 4 sectors facing the biggest impact, global brokerages decodeThe Trump administration's 26% tariff on Indian imports has led to significant market reactions and economic concerns. Pharmaceuticals rema...
- No chill, just pills! Pharma stocks slide up to 8% as Trump does yes-no-yes on tariffShares of Indian pharma companies, including Aurobindo Pharma, Laurus Labs, IPCA Labs, and Lupin, fell up to 8% after U.S. President Donald...
- Zydus Lifesciences shares zoom 7% after USFDA nod for Dasatinib tabletsZydus Lifesciences share price: Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multi...
- LIC Housing Finance shares jump 2% as board approves Rs 1.23 lakh crore borrowing plan for FY26LIC Housing Finance shares saw a rise after its board approved a significant borrowing plan of Rs 1.23 lakh crore for FY26 through various ...
- TCS shares in focus after partnership with Vantage Towers for telecom site management platformTCS has partnered with Vantage Towers, Europe’s second-largest telecom tower operator, to launch a digital service platform to enhance prop...
- Wipro shares in focus after launch of AI-first platform TelcoAI360 to help telecom sector cut costsDeveloped in collaboration with Wipro’s AI partner ecosystem and leveraging ServiceNow’s telecommunications industry solutions suite, Telco...
- Hot stocks: Brokerage view on Bajaj Auto, KEI Industries, Zydus Life and L&T TechMacquarie rates Bajaj Auto as neutral citing disappointing gross margins, while Jefferies is optimistic on KEI Industries, raising its targ...
- Jefferies upgrades Zydus Life to 'Buy' on strong US pipeline potential, stock up 4%Global brokerage firm Jefferies has upgraded Zydus Lifesciences to a 'Buy' rating, citing the strength of the company’s US pipeline as a ma...
- Hot stocks: Brokerage view on L&T Finance, IndiGo and Zydus LifesciencesAxis Capital has downgraded IndiGo from a buy rating to an add rating, though it has raised the target price to Rs 5,100 from Rs 4,700. The...
- Hot Stocks: Brokerage view on Phoenix Mills, Anupam Rasayan; CLSA downgrades DelhiveryCLSA downgraded Delhivery to underperform, Jefferies raised Zydus Life target, and Anupam Rasayan had balance sheet concerns. Citigroup rec...
- Hot Stocks: Brokerage view on Eicher Motors, Wipro and Adani EnterprisesThe global investment bank sees 47%/50% CAGR for Airport/ANIL EBITDA over FY24-FY28. The balance sheet is well-placed to take up the rise i...
- Hot Stocks: Brokerages on Zydus Life, Hindalco, Anupam Rasayan and Alkem LaboratoriesMacquarie maintained an underperform rating on Zydus Life with a target price of Rs 490. The Q2FY24 results were a mixed bag.
- Hot Stocks: Brokerage view on Zomato, Star Health, Zydus Life and NykaaMorgan Stanley maintained an overweight rating on Zomato but raised the target price to Rs 125 from Rs 115 earlier.
- Q3 results impact: Tata Motors, Zomato among over 35 stock upgrades and downgradesA team of analysts from global brokerage firm Jefferies has raised the FY23 earnings estimates for 47% of 147 companies under its coverage ...
- Sensex & Nifty targets, market prediction, top stock picks from 10 brokerages for your 2023 portfolioTop stock picks: The brokerage is bullish on private banks, insurance, select industrials, consumer discretionary, automobiles and telcos. ...
- Advent set to buy controlling stake in Bharat SerumKotak PE and OrbiMed together that hold 23% stake in Mumbai-based biopharma company Bharat Serums and Vaccines (BSV) are exiting through th...
- Advent International emerges sole bidder for Bharat SerumsKotak PE and OrbiMed together hold 23% stake in BSV. The rest of the stake is with the Daftary family.
- Baxter emerges as frontrunner to buy KKR-backed Gland Pharma for $1.1-1.2 billionHyderabad-headquartered Gland is a leading contract manufacturers of injectables, supplying to pharma majors in India and US like Dr Reddy’...
- Gland Pharma promoters put their 60 per cent stake on the blockPromoters of Hyderabad-based speciality injectable drugs maker Gland Pharma have decided to put their controlling stake on the block.
Load More
